MY AMERICAN SCIENTIST
LOG IN! REGISTER!
SEARCH
 
RSS
Logo
HOME > SCIENCE IN THE NEWS > Science Detail

SCIENCE IN THE NEWS DAILY

Swedes Implant Tissue-Engineered Vein in 10-Year-Old Girl

from the Los Angeles Times (Registration Required)

Swedish researchers have, for the first time, implanted a tissue-engineered vein made from her own stem cells into a 10-year-old girl. The implant of the portal vein had to be repeated after a year, but the team reported that the new vein dramatically improved the young girl's quality of life, allowing her to grow taller, gain weight and begin exercising.

The portal vein drains blood from the intestines and spleen to the liver, and blockages, which are usually genetic in origin, can cause serious medical complications such as enlarging the spleen and stunting growth. It can even be fatal. Normal treatment is to transplant a vein taken from the leg or the deep neck, but surgery to remove the vein can cause limb problems. The transplanted vein can also lead to loss of the liver and the need for an organ transplant.

Researchers have also been working with artificial veins made of Dacron or polytetrafluoroethylene, but have encountered problems with those as well. The synthetic grafts often fail, particularly if the vein is small.

Read more...


 

Sign Up

... for Sigma Xi SmartBrief, a free daily summary of the latest news in scientific research, delivered straight to your in-box. Each story is summarized concisely and linked directly to the original source for further reading.

Click here to subscribe.


Subscribe to Our Content!

Visit our RSS Feeds page to choose among 13 customized feeds, or create a free My AmSci account to request an email notice whenever a specified author, department or discipline appears online.


EMAIL TO A FRIEND :

Of Possible Interest

Science In The News Daily: Therapeutic Antibody Pioneers Get Spain's Top Science Prize

Science In The News Daily: Flavour Changer: Genome Could Enhance Tomato Taste

Science In The News Daily: Stem Cells Take Root in Drug Development

Subscribe to American Scientist